Summary Medgenics Inc. (Medgenics) is a biopharmaceutical company. The company develops unique technology platform for the express purpose of treating patients with rare genetic and orphan diseases. It offers pipeline products such as MDGN-201, MDGN-204, MDGN-205 and MDGN-206. Medgenics’s pipeline products is to treat renal anemia, orphan metabolic syndrome, orphan gi syndrome and orphan enzyme replacement. The company operates with BioPump technology to implant into patient where it produces a therapeutic protein (biologic drug). It produces proteins, peptides, and other molecules. Medgenics is headquartered in Wayne, Pennsylvania, the US. Medgenics Inc. (MEDG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in... Research Beam Model: Research Beam Product ID: 129805 250 USD New
Medgenics Inc. (MEDG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Medgenics Inc. (MEDG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : July   2014
  • Pages : 25
  • Publisher : GlobalData
 
 
 
Summary

Medgenics Inc. (Medgenics) is a biopharmaceutical company. The company develops unique technology platform for the express purpose of treating patients with rare genetic and orphan diseases. It offers pipeline products such as MDGN-201, MDGN-204, MDGN-205 and MDGN-206. Medgenics’s pipeline products is to treat renal anemia, orphan metabolic syndrome, orphan gi syndrome and orphan enzyme replacement. The company operates with BioPump technology to implant into patient where it produces a therapeutic protein (biologic drug). It produces proteins, peptides, and other molecules. Medgenics is headquartered in Wayne, Pennsylvania, the US.

Medgenics Inc. (MEDG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
Medgenics Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 6
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 8
Medgenics Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 9
Medgenics Inc., Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Medgenics Extends Co-Development Agreement With Baxter Healthcare 10
Medgenics Enters Into Co-Development Agreement With Baxter Healthcare 11
Licensing Agreements 12
Medgenics Enters Into Licensing Agreement With Regents Of The University Of Michigan 12
Equity Offering 13
Medgenics Completes Underwriters' Exercise Of Over-Allotment Option For Public Offering Of Shares For US$32.5 Million 13
Medgenics Completes Private Placement Of Units For US$9.5 Million 15
Medgenics Issues Additional Shares Upon Partial Exercise Of Underwriter's Over Allotment Option 16
Medgenics Completes Private Placement Of US$1.2 Million 18
Medgenics Completes Private Placement Of US$1.1 Million 19
Medgenics Completes Private Placement Of US$0.39 Million 20
Debt Offering 21
Medgenics Completes Private Placement Of Convertible Debentures For US$4 Million 21
Medgenics Inc. - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List Of Tables
List of Tables
Medgenics Inc., Pharmaceuticals & Healthcare, Key Facts, 2013 1
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 1
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 1
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 1
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
Medgenics Inc., Pharmaceuticals & Healthcare Deals By Type, 2008 to YTD 2014 6
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
Medgenics Inc., Deals By Therapy Area, 2008 to YTD 2014 8
Medgenics Inc., Pharmaceuticals & Healthcare, Deals Summary, 2008 to YTD 2014 9
Medgenics Extends Co-Development Agreement With Baxter Healthcare 10
Medgenics Enters Into Co-Development Agreement With Baxter Healthcare 11
Medgenics Enters Into Licensing Agreement With Regents Of The University Of Michigan 12
Medgenics Completes Underwriters' Exercise Of Over-Allotment Option For Public Offering Of Shares For US$32.5 Million 13
Medgenics Completes Private Placement Of Units For US$9.5 Million 15
Medgenics Issues Additional Shares Upon Partial Exercise Of Underwriter's Over Allotment Option 16
Medgenics Completes Private Placement Of US$1.2 Million 18
Medgenics Completes Private Placement Of US$1.1 Million 19
Medgenics Completes Private Placement Of US$0.39 Million 20
Medgenics Completes Private Placement Of Convertible Debentures For US$4 Million 21
Medgenics Inc., Key Competitors 22
Medgenics Inc., Key Employees 23
Medgenics Inc., Subsidiaries 24
List Of Figures
List of Figures
Medgenics Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 1
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014 5
Medgenics Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014 6
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Region, 2008 to YTD 2014 7
Medgenics Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2008 to YTD 2014 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter